Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
300.58 USD | -1.16% |
|
-1.03% | -40.58% |
Company Valuation: UnitedHealth Group Inc.
Data adjusted to current consolidation scope
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 332,732 | 472,941 | 495,373 | 486,945 | 465,535 | 272,668 | - | - |
Change | - | 42.14% | 4.74% | -1.7% | -4.4% | -41.43% | - | - |
Enterprise Value (EV) 1 | 359,278 | 495,037 | 514,300 | 519,854 | 513,326 | 316,167 | 310,219 | 307,034 |
Change | - | 37.79% | 3.89% | 1.08% | -1.26% | -38.41% | -1.88% | -1.03% |
P/E ratio | 21.9x | 27.8x | 25x | 22.1x | 32.6x | 14.3x | 12.2x | 10.5x |
PBR | 5.1x | 6.28x | 6.18x | 5.48x | 5x | 2.71x | 2.5x | 2.27x |
PEG | - | 2.2x | 1.5x | 1.7x | -0.9x | 0.4x | 0.7x | 0.6x |
Capitalization / Revenue | 1.29x | 1.64x | 1.53x | 1.31x | 1.16x | 0.61x | 0.57x | 0.53x |
EV / Revenue | 1.4x | 1.72x | 1.59x | 1.4x | 1.28x | 0.7x | 0.65x | 0.6x |
EV / EBITDA | 14.2x | 18.3x | 16.2x | 14.3x | 14.1x | 9.22x | 8x | 6.95x |
EV / EBIT | 16x | 20.7x | 18.1x | 16.1x | 15.9x | 10.5x | 8.95x | 7.73x |
EV / FCF | 17.9x | 24.9x | 22x | 20.2x | 24.8x | 12.3x | 11.3x | 9.76x |
FCF Yield | 5.6% | 4.02% | 4.55% | 4.94% | 4.03% | 8.11% | 8.87% | 10.2% |
Dividend per Share 2 | 4.83 | 5.6 | 6.4 | 7.29 | 8.18 | 8.563 | 9.341 | 9.624 |
Rate of return | 1.38% | 1.12% | 1.21% | 1.38% | 1.62% | 2.85% | 3.11% | 3.2% |
EPS 2 | 16.03 | 18.08 | 21.18 | 23.86 | 15.51 | 20.99 | 24.58 | 28.75 |
Distribution rate | 30.1% | 31% | 30.2% | 30.6% | 52.7% | 40.8% | 38% | 33.5% |
Net sales 1 | 257,141 | 287,597 | 324,162 | 371,622 | 400,278 | 449,431 | 478,290 | 512,074 |
EBITDA 1 | 25,296 | 27,073 | 31,835 | 36,330 | 36,386 | 34,309 | 38,789 | 44,190 |
EBIT 1 | 22,405 | 23,970 | 28,435 | 32,358 | 32,287 | 30,100 | 34,667 | 39,711 |
Net income 1 | 15,403 | 17,285 | 20,120 | 22,381 | 14,405 | 19,516 | 22,474 | 25,869 |
Net Debt 1 | 26,546 | 22,096 | 18,927 | 32,909 | 47,791 | 43,499 | 37,551 | 34,365 |
Reference price 2 | 350.68 | 502.14 | 530.18 | 526.47 | 505.86 | 300.58 | 300.58 | 300.58 |
Nbr of stocks (in thousands) | 948,821 | 941,851 | 934,349 | 924,925 | 920,284 | 907,140 | - | - |
Announcement Date | 1/20/21 | 1/19/22 | 1/13/23 | 1/12/24 | 1/16/25 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
---|---|---|---|---|---|---|
14.32x | 0.7x | 9.22x | 2.85% | 273B | ||
12.8x | 0.39x | 7.91x | 1.91% | 80.96B | ||
11.09x | 0.5x | 7.74x | 2.01% | 76.83B | ||
14.83x | 0.28x | 8.59x | 1.62% | 27.45B | ||
14.59x | 0.12x | 10.85x | 5.44% | 15.25B | ||
10.6x | 0.22x | 5x | -.--% | 11.87B | ||
-38.88x | 0.65x | 47.85x | -.--% | 2.65B | ||
42.94x | 1.41x | 8.7x | -.--% | 2.01B | ||
-24.13x | 0.71x | 23.6x | -.--% | 1.53B | ||
Average | 6.46x | 0.55x | 14.38x | 1.54% | 54.58B | |
Weighted average by Cap. | 13.22x | 0.57x | 8.94x | 2.47% |
Year-on-year evolution of the PER
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- UNH Stock
- Valuation UnitedHealth Group Inc.
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition